Dr. Juan Gómez Rivas

An expert in urological oncology, specializing in prostate, bladder, and kidney cancer, as well as laparoscopic and robotic surgery, Dr. Juan Gómez Rivas has been part of our unit since 2019.

Current specialization

Their healthcare activity is focused on the field of genitourinary tumorsFrom localized disease to advanced stages of the disease, encompassing both medical and surgical management in its different approaches (open, minimally invasive, focal) of the different tumors of prostate, kidney, bladderamong others. He is also a member of the kidney transplant team at the San Carlos Clinical Hospital Madrid.

In addition to being a member of Institute of Advanced Urology (ICUA) combines his work as a specialist urologist in the Area in the San Carlos Clinical Hospital MadridHe has also worked as a teacher and observer at various prestigious institutions both in Spain and abroad. In addition, he is a speaker and director of numerous national and international courses.

He collaborates as a lecturer in Urology at the Complutense University of Madrid in undergraduate education and as a professor of Master's degree in multidisciplinary approach to Prostate Cancer.

Academic activities and membership in organizations

He actively works in several scientific societies such as:

  • President of the Young Academics Urologistst (YAU) of the European Association of Urology(UAE)
  • Member of the Board of Directors of theYoung Urologist Office (YUO) of the European Association of Urology (UAE).
  • Member of the Board of Directors of the European School of Urology(ESU) of the European Association of Urology (UAE).
  • Associate Member of the European Section of Uro-Technology(ESUT-UAE). Ablative therapies group.
  • Director of the Continuing Education Office of the Spanish Association of Urology(AEU).
  • Member of the Spanish Society for Surgical Research (SEIQ).

Scientific activity

He actively participates in the world of research as a member of the Health Research Institute of San Carlos Clinical Hospital (IdISSC) within the area of ​​clinical and translational research in oncology. Finally, Dr. Gómez Rivas's extensive curriculum vitae is complemented by his authorship and collaboration on more than 170 scientific publications, monographs, book chapters, and his participation in national and international meetings and congresses.

Click here to learn more about their medical supplies list.

  1. Morozov A, Barret E, Veneziano D, Grigoryan V, Salomon G, Fokin I, Taratkin M, Poddubskaya E, Gomez Rivas J, Puliatti S, Okhunov Z, Cacciamani GE, Checcucci E, Marenco Jiménez JL, Enikeev D. A systematic review of nerve-sparing surgery for high-risk prostate cancer. Minerva Urol Nefrol. 2021 Jun;73(3):283-291. PMID: 33439578.
  2. Mori K, Miura N, Comperat E, Nikles S, Pang KH, Misrai V, Gomez Rivas J, Papalia R, Shariat SF, Esperto F, Pradere B. A systematic review and meta-analysis of prognostic impact of different Gleason patterns in ISUP grade group 4. Minerva Urol Nephrol. 2021 Feb;73(1):42-49. PMID: 32432435.
  3. Taratkin M, Álvarez-Maestro M, Gómez Rivas J. The need of avoiding unnecessary biopsies in active surveillance for prostate cancer. Actas Urol Esp. Jul-Aug 2021;45(6):417-418. PMID: 33637377.
  4. Morozov A, Kozlov V, Rivas JG, Teoh JY, Bezrukov E, Amosov A, Barret E, Taratkin M, Salomon G, Herrmann TRW, Gozen A, Enikeev D; collaboration between ESUT, ESUI and Uro-technology WP of the Young Academic Urologists. A systematic review and meta-analysis of Histoscanning™ in prostate cancer diagnoses. World J Urol. 2021 Apr 7. doi: 10.1007/s00345-021-03684-8. PMID: 33825986.
  5. Marchioni M, Rivas JG, Autran A, Socarras M, Albisinni S, Ferro M, Schips L, Scarpa RM, Papalia R, Esperto F. Biomarkers for Renal Cell Carcinoma Recurrence: State of the Art. Curr Urol Rep. 2021 Apr 22;22(6):31. PMID: 33886004.
  6. Khadhouri S, Gallagher KM, MacKenzie KR, Shah TT, Gao C, Moore S, Zimmermann EF, Edison E, Jefferies M, Nambiar A, Mannas MP, Lee T, Marra G, Lillaz B, Gómez Rivas J, Olivier J, Assmus MA, Uçar T, Claps F, Boltri M, Burnhope T, Nkwam N, Tanasescu G, Boxall NE, Downey AP, Lal AA, Antón-Juanilla M, Clarke H, Hw Lau D, Gillams K, Crockett M, Nielsen M, Takwoingi Y, Chuchu N, O'Rourke J, MacLennan G, McGrath JS, Kasivisvanathan V; IDENTIFY Study group. The IDENTIFY Study: The Investigation and Detection of Urological Neoplasia in Patients Referred with Suspected Urinary Tract Cancer; A multicenter observational study. BJU Int. 2021 Oct;128(4):440-450. PMID: 33991045.
  7. Socarrás MR, Elbers JR, Rivas JG, Autran AM, Esperto F, Tortolero L, Carrion D, Sancha FG. Retroperitoneal Robot-Assisted Partial Nephrectomy (rRAPN): Surgical Technique and Review. Curr Urol Rep. 2021 May 20;22(6):33. doi:10.1007/s11934-021-01051-z. PMID: 34014412.
  8. Alvarez-Maestro, J. Gomez Rivas, M. Moschini. Surgery for oligometastatic prostate cancer: Where are we going?. Urol Esp Proceedings (Engl Ed). 2021 Sep;45(7):479-480. PMID: 34330693.
  9. Esperto F, Prata F, Autrán-Gómez AM, Rivas JG, Socarras M, Marchioni M, Albisinni S, Cataldo R, Scarpa RM, Papalia R. New Technologies for Kidney Surgery Planning 3D, Impression, Augmented Reality 3D, Reconstruction: Current Realities and Expectations. Curr Urol Rep. 2021 May 25;22(7):35. PMID: 34031768.
  10. Moises Rodriguez Socarrás, Juan Gómez Rivas, Jeremy Yuen-Chun Teoh, Javier Puente, Marco Moschini, Jesús Moreno-Sierra. The Uro-oncology Patient and Vaccination Against SARS-CoV-2. Eur Urol Open Sci. 2021 Jul;29:77-81. PMID: 34075362
  11. Elbers JR, Rodríguez Socarrás M, Rivas JG, Autran AM, Esperto F, Tortolero L, Carrion DM, Sancha FG. Robotic Repair of Ureteral Strictures: Techniques and Review. Curr Urol Rep. 2021 Jun 9;22(8):39. PMID: 34105032.
  12. García-Perdomo HA, Gómez-Ospina JC, Chaves-Medina MJ, Sierra JM, Gómez AMA, Rivas JG. Impact of lifestyle in prostate cancer patients. What should we do? Int Braz J Urol. 2021 Sep 2;47. doi: 10.1590/S1677-5538.IBJU.2021.0297. Epub ahead of print. PMID: 34472770.
  13. Cacciamani GE, Matulewicz RS, Kumar R, Teoh JY, Mari A, Pradere B, Gomez Rivas J, Necchi A, Kumar Pal S, Ribal MJ, Shariat S, Rink M; SMART (Stop sMoking for Advance Rehabilitation Treatments) Urology Working Group. Fighting the 'tobacco epidemic' – A call to action to identify Targeted Intervention Points (TIPs) for better counseling patients with urothelial cancer. Urol Oncol. 2021 Dec;39(12):793-796. MID: 34629283.
  14. Dilme RV, Rivas JG, Campi R, Puente J, Jerez T, Enikeev D, Esperto F, Sierra JM. Cytoreductive Nephrectomy in the Management of Metastatic Renal Cell Carcinoma: Is There Still a Debate? Curr Urol Rep. 2021 Oct 16;22(11):54. doi:10.1007/s11934-021-01073-7. PMID: 34654989.
  15. Lonati C, Necchi A, Gómez Rivas J, Afferi L, Laukhtina E, Martini A, Ventimiglia E, Colombo R, Gandaglia G, Salonia A, Briganti A, Montorsi F, Mattei A, Simeone C, Carlo MI, Shariat SF, Spiess PE, Moschini M. Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumor Spectrum: A Comprehensive Overview from the European Association of Urology – Young Academic Urologists and the Global Society of Rare Genitourinary Tumors. Eur Urol Oncol. 2021 Dec 9:S2588-9311(21)00189-9. doi: 10.1016/j.euo.2021.11.001. Epub ahead of print. PMID: 34896051.
  16. Gallioli A, Rivas JG, Larcher A, Breda A. Living Donor Robot-Assisted Kidney Transplantation: a New Standard of Care? Curr Urol Rep. 2021 Dec 16;22(12):58.
  17. Vidal N, Gómez Rivas J, Fernández L, Moreno J, Puente J. The past, present, and future of non-metastatic castration-resistant prostate cancer (nmCRPC): a narrative review. Precis Cancer Med Online First [Internet]. 2022; Available from: https://pcm.amegroups.com/article/view/6795.
  18. Toribio-Vázquez, J., Gómez Rivas, Á., Yebes, DM, Carrión, M., Yagüe Barrado, M., Álvarez-Maestro, L., Martínez-Piñeiro. New strategies in decision-making in prostate cancer. The role of Oncotype DX. Actas Urológicas Españolas, 2022. https://doi.org/10.1016/j.acuro.2022.01.001.
  19. John G.R., Laura FH, Javier PV, Natalia VC, Mᵃ Isabel GR, Enrique RG, José Luis SP, Pablo AL, Noelia SS, Roser VD, Jesús MS. Where Do We Stand in the Management of Oligometastatic Prostate Cancer? A Comprehensive Review. cancers. 2022; 14 (8): 2017. https://doi.org/10.3390/cancers14082017.
  20. Roberts S, Desai A, Checcucci E, Puliatti S, Taratkin M, Kowalewski KF, Gomez Rivas J, Rivero I, Veneziano D, Autorino R, Porpiglia F, Gill IS, Cacciamani GE. “Augmented reality” applications in urology: a systematic review. Minerva Urol Nephrol. 2022 Apr 6. doi: 10.23736/S2724-6051.22.04726-7. PMID: 35383432.

Diseases it treats

Prostate Cancer

It is the most common cancer in men, and it is curable if detected early. It is important to see a urologist annually starting at age 50 for early detection, and at age 40 if there is a family history.

Kidney Cancer

It's a tumor that initially causes few symptoms; the kidney is surrounded by a layer of fat that allows it to grow without causing any problems. Nowadays, it's detected during routine imaging studies (ultrasound, CT scan, MRI).

Bladder Cancer

Very common in patients who smoke or who smoked in their youth, it usually presents with blood in the urine and irritative urinary symptoms. 80% of cases are curable.

Testicular Cancer

It is a cancer that primarily affects young men. It can be of different types depending on the type of cell it affects, and its main symptom is the appearance of a painless lump in the testicle.

penile cancer

It is a rare cancer, curable when detected early; its detection is difficult in uncircumcised men; you should consult a doctor if you notice any lump or ulcer on the penis, discharge, or bleeding.

Techniques in which he specializes

Robotic surgery

The Da Vinci Robot allows surgery through small holes in the abdominal wall, increasing the surgeon's precision and ability to perform procedures with great delicacy.

Laparoscopic and robotic pyeloplasty

Laparoscopic or robotic pyeloplasty is a minimally invasive surgical procedure performed to treat strictures at the junction between the renal pelvis and the ureter. The procedure reconstructs this junction to allow urine to flow…

Focal therapy for localized prostate cancer

A non-invasive technique that destroys cancerous tissue using various energy sources. HIFU treatment uses ultrasonic energy, or sound waves, to heat and destroy specific areas of prostate tissue. Cryotherapy uses cold with the same…

Prostate mapping

Fusion biopsy projects the prostate MRI images onto those obtained in real time in the operating room with ultrasound and allows the biopsy to be directed with great precision to the areas of suspicion of cancer.

Hospitals where he/she works

Last News

Articles by Dr. Gómez Rivas